A Ceftazidime-Avibactam-Resistant and Carbapenem-Susceptible Klebsiella pneumoniae Strain Harboring blaKPC-14 Isolated in New York City
- PMID: 32848008
- PMCID: PMC7449627
- DOI: 10.1128/mSphere.00775-20
A Ceftazidime-Avibactam-Resistant and Carbapenem-Susceptible Klebsiella pneumoniae Strain Harboring blaKPC-14 Isolated in New York City
Abstract
Ceftazidime-avibactam is a potent antibiotic combination against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae Here, we describe a unique ceftazidime-avibactam-resistant and carbapenem-susceptible K. pneumoniae strain harboring a novel blaKPC-14 variant. This strain was isolated from a New York City patient in 2003, which predates the introduction of avibactam. Despite resistance to ceftazidime-avibactam, the strain was susceptible to imipenem-relebactam and meropenem-vaborbactam. Comprehensive genomic sequencing revealed that blaKPC-14 is harbored on an ST6 IncN plasmid associated with the early spread of blaKPCIMPORTANCE KPC is currently the most common carbapenemase identified in the United States. More than 40 KPC variants have been described, of which KPC-2 and KPC-3 are the most frequent clinical variants. However, our understanding of the genetic structures and β-lactam resistance profiles of other novel KPC variants remains incomplete. Here, we report a novel blaKPC variant (blaKPC-14) and the complete genome sequence of blaKPC-14-harboring K. pneumoniae strain BK13048, which is susceptible to carbapenems but resistant to ceftazidime-avibactam. To the best of our knowledge, this is one of the earliest KPC-producing K. pneumoniae strains exhibiting resistance to ceftazidime-avibactam.
Keywords: KPC; antimicrobial resistance; carbapenem; ceftazidime-avibactam; plasmid; selection.
Copyright © 2020 Niu et al.
Figures

Similar articles
-
Evolution of ceftazidime-avibactam resistance driven by variation in bla KPC-2 to bla KPC-190 during treatment of ST11-K64 hypervirulent Klebsiella pneumoniae.Front Cell Infect Microbiol. 2025 Jun 6;15:1607127. doi: 10.3389/fcimb.2025.1607127. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40546282 Free PMC article.
-
Mutant prevention concentrations, in vitro resistance evolution dynamics, and mechanisms of resistance to imipenem and imipenem/relebactam in carbapenem-susceptible Klebsiella pneumoniae isolates showing ceftazidime/avibactam resistance.Antimicrob Agents Chemother. 2024 Dec 5;68(12):e0112024. doi: 10.1128/aac.01120-24. Epub 2024 Nov 15. Antimicrob Agents Chemother. 2024. PMID: 39545736 Free PMC article.
-
Whole-genome sequencing characterisation of a new KPC-245 variant-carrying Klebsiella pneumoniae strain isolated from a transplanted patient and resistant to ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam.J Glob Antimicrob Resist. 2025 May;42:229-233. doi: 10.1016/j.jgar.2025.03.006. Epub 2025 Mar 18. J Glob Antimicrob Resist. 2025. PMID: 40113084
-
Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview.Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0044722. doi: 10.1128/aac.00447-22. Epub 2022 Aug 18. Antimicrob Agents Chemother. 2022. PMID: 35980232 Free PMC article. Review.
-
Use of carbapenems in the combined treatment of emerging ceftazidime/avibactam-resistant and carbapenem-susceptible KPC-producing Klebsiella pneumoniae infections: Report of a case and review of the literature.J Glob Antimicrob Resist. 2020 Sep;22:9-12. doi: 10.1016/j.jgar.2019.11.007. Epub 2019 Nov 13. J Glob Antimicrob Resist. 2020. PMID: 31733412 Review.
Cited by
-
KPC-2 allelic variants in Klebsiella pneumoniae isolates resistant to ceftazidime-avibactam from Argentina: blaKPC-80, blaKPC-81, blaKPC-96 and blaKPC-97.Microbiol Spectr. 2024 Mar 5;12(3):e0411123. doi: 10.1128/spectrum.04111-23. Epub 2024 Feb 6. Microbiol Spectr. 2024. PMID: 38319084 Free PMC article.
-
Molecular mechanisms underlying bacterial resistance to ceftazidime/avibactam.WIREs Mech Dis. 2022 Nov;14(6):e1571. doi: 10.1002/wsbm.1571. Epub 2022 Jul 26. WIREs Mech Dis. 2022. PMID: 35891616 Free PMC article. Review.
-
Impact of the double deletion ΔG242-T243 in KPC-2 in the effectiveness of ceftazidime-avibactam and imipenem-relebactam.Antimicrob Agents Chemother. 2025 Jun 4;69(6):e0191524. doi: 10.1128/aac.01915-24. Epub 2025 May 5. Antimicrob Agents Chemother. 2025. PMID: 40323374 Free PMC article.
-
Klebsiella pneumoniae carbapenemase variants: the new threat to global public health.Clin Microbiol Rev. 2023 Dec 20;36(4):e0000823. doi: 10.1128/cmr.00008-23. Epub 2023 Nov 8. Clin Microbiol Rev. 2023. PMID: 37937997 Free PMC article. Review.
-
Global Epidemiology and Antimicrobial Resistance of Klebsiella Pneumoniae Carbapenemase (KPC)-Producing Gram-Negative Clinical Isolates: A Review.Microorganisms. 2025 Jul 19;13(7):1697. doi: 10.3390/microorganisms13071697. Microorganisms. 2025. PMID: 40732206 Free PMC article. Review.
References
-
- Shields RK, Chen L, Cheng S, Chavda KD, Press EG, Snyder A, Pandey R, Doi Y, Kreiswirth BN, Nguyen MH, Clancy CJ. 2017. Emergence of ceftazidime-avibactam resistance due to plasmid-borne blaKPC-3 mutations during treatment of carbapenem-resistant Klebsiella pneumoniae infections. Antimicrob Agents Chemother 61:e02097-16. doi:10.1128/AAC.02097-16. - DOI - PMC - PubMed
-
- Giddins MJ, Macesic N, Annavajhala MK, Stump S, Khan S, McConville TH, Mehta M, Gomez-Simmonds A, Uhlemann AC. 2018. Successive emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in blaKPC-2-harboring Klebsiella pneumoniae sequence type 307 isolates. Antimicrob Agents Chemother 62:e02101-17. doi:10.1128/AAC.02101-17. - DOI - PMC - PubMed
-
- Shields RK, Potoski BA, Haidar G, Hao B, Doi Y, Chen L, Press EG, Kreiswirth BN, Clancy CJ, Nguyen MH. 2016. Clinical outcomes, drug toxicity, and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections. Clin Infect Dis 63:1615–1618. doi:10.1093/cid/ciw636. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical